United States General Anesthesia Drug Market Research Report Forecast 2017-2021

March 2017 | 120 pages | ID: U8AB2AF8ECDEN
S&P Consulting

Abstracts

The United States General Anesthesia Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the General Anesthesia Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This General Anesthesia Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

AstraZeneca
Fresenius-Kabi
BbVie Laboratories
Baxter Healthcare
Braun
Maruishi
Piramal Healthcare
Hikma Pharmaceuticals
Mylan

United States General Anesthesia Drug Market: Product Segment Analysis

Inhalation Anesthestic
Intravenous Anesthestic
Type 3

United States General Anesthesia Drug Market: Application Segment Analysis

Hospital Use
Clinic Use
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

United States General Anesthesia Drug Market Research Report Forecast 2017-2021

CHAPTER 1 GENERAL ANESTHESIA DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of General Anesthesia Drug
1.2 General Anesthesia Drug Market Segmentation by Type
  1.2.1 United States Production Market Share of General Anesthesia Drug by Type in 2015
  1.2.1 Inhalation Anesthestic
  1.2.2 Intravenous Anesthestic
  1.2.3 Type
1.3 General Anesthesia Drug Market Segmentation by Application
  1.3.1 General Anesthesia Drug Consumption Market Share by Application in 2015
  1.3.2 Hospital Use
  1.3.3 Clinic Use
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of General Anesthesia Drug (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON GENERAL ANESTHESIA DRUG INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES GENERAL ANESTHESIA DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 United States General Anesthesia Drug Production and Share by Manufacturers (2015 and 2016)
3.2 United States General Anesthesia Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States General Anesthesia Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers General Anesthesia Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 General Anesthesia Drug Market Competitive Situation and Trends
  3.5.1 General Anesthesia Drug Market Concentration Rate
  3.5.2 General Anesthesia Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES GENERAL ANESTHESIA DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States General Anesthesia Drug Production and Market Share by Type (2012-2017)
4.2 United States General Anesthesia Drug Revenue and Market Share by Type (2012-2017)
4.3 United States General Anesthesia Drug Price by Type (2012-2017)
4.4 United States General Anesthesia Drug Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES GENERAL ANESTHESIA DRUG MARKET ANALYSIS BY APPLICATION

5.1 United States General Anesthesia Drug Consumption and Market Share by Application (2012-2017)
5.2 United States General Anesthesia Drug Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES GENERAL ANESTHESIA DRUG MANUFACTURERS ANALYSIS

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Fresenius-Kabi
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 BbVie Laboratories
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Baxter Healthcare
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Braun
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Maruishi
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Piramal Healthcare
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Hikma Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Mylan
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 GENERAL ANESTHESIA DRUG MANUFACTURING COST ANALYSIS

7.1 General Anesthesia Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of General Anesthesia Drug

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 General Anesthesia Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of General Anesthesia Drug Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES GENERAL ANESTHESIA DRUG MARKET FORECAST (2017-2021)

11.1 United States General Anesthesia Drug Production, Revenue Forecast (2017-2021)
11.2 United States General Anesthesia Drug Production, Consumption Forecast by Regions (2017-2021)
11.3 United States General Anesthesia Drug Production Forecast by Type (2017-2021)
11.4 United States General Anesthesia Drug Consumption Forecast by Application (2017-2021)
11.5 General Anesthesia Drug Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of General Anesthesia Drug
Table Classification of General Anesthesia Drug
Figure United States Sales Market Share of General Anesthesia Drug by Type in 2015
Table Application of General Anesthesia Drug
Figure United States Sales Market Share of General Anesthesia Drug by Application in 2015
Figure United States General Anesthesia Drug Sales and Growth Rate (2011-2021)
Figure United States General Anesthesia Drug Revenue and Growth Rate (2011-2021)
Table United States General Anesthesia Drug Sales of Key Manufacturers (2015 and 2016)
Table United States General Anesthesia Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 General Anesthesia Drug Sales Share by Manufacturers
Figure 2016 General Anesthesia Drug Sales Share by Manufacturers
Table United States General Anesthesia Drug Revenue by Manufacturers (2015 and 2016)
Table United States General Anesthesia Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States General Anesthesia Drug Revenue Share by Manufacturers
Table 2016 United States General Anesthesia Drug Revenue Share by Manufacturers
Table United States Market General Anesthesia Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market General Anesthesia Drug Average Price of Key Manufacturers in 2015
Figure General Anesthesia Drug Market Share of Top 3 Manufacturers
Figure General Anesthesia Drug Market Share of Top 5 Manufacturers
Table United States General Anesthesia Drug Sales by Type (2012-2017)
Table United States General Anesthesia Drug Sales Share by Type (2012-2017)
Figure United States General Anesthesia Drug Sales Market Share by Type in 2015
Table United States General Anesthesia Drug Revenue and Market Share by Type (2012-2017)
Table United States General Anesthesia Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of General Anesthesia Drug by Type (2012-2017)
Table United States General Anesthesia Drug Price by Type (2012-2017)
Figure United States General Anesthesia Drug Sales Growth Rate by Type (2012-2017)
Table United States General Anesthesia Drug Sales by Application (2012-2017)
Table United States General Anesthesia Drug Sales Market Share by Application (2012-2017)
Figure United States General Anesthesia Drug Sales Market Share by Application in 2015
Table United States General Anesthesia Drug Sales Growth Rate by Application (2012-2017)
Figure United States General Anesthesia Drug Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca General Anesthesia Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca General Anesthesia Drug Market Share (2012-2017)
Table Fresenius-Kabi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Fresenius-Kabi General Anesthesia Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Fresenius-Kabi General Anesthesia Drug Market Share (2012-2017)
Table BbVie Laboratories Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BbVie Laboratories General Anesthesia Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table BbVie Laboratories General Anesthesia Drug Market Share (2012-2017)
Table Baxter Healthcare Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Baxter Healthcare General Anesthesia Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Baxter Healthcare General Anesthesia Drug Market Share (2012-2017)
Table Braun Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Braun General Anesthesia Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Braun General Anesthesia Drug Market Share (2012-2017)
Table Maruishi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Maruishi General Anesthesia Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Maruishi General Anesthesia Drug Market Share (2012-2017)
Table Piramal Healthcare Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Piramal Healthcare General Anesthesia Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Piramal Healthcare General Anesthesia Drug Market Share (2012-2017)
Table Hikma Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hikma Pharmaceuticals General Anesthesia Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Hikma Pharmaceuticals General Anesthesia Drug Market Share (2012-2017)
Table Mylan Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Mylan General Anesthesia Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Mylan General Anesthesia Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of General Anesthesia Drug
Figure Manufacturing Process Analysis of General Anesthesia Drug
Figure General Anesthesia Drug Industrial Chain Analysis
Table Raw Materials Sources of General Anesthesia Drug Major Manufacturers in 2015
Table Major Buyers of General Anesthesia Drug
Table Distributors/Traders List
Figure United States General Anesthesia Drug Production and Growth Rate Forecast (2017-2021)
Figure United States General Anesthesia Drug Revenue and Growth Rate Forecast (2017-2021)
Table United States General Anesthesia Drug Production Forecast by Type (2017-2021)
Table United States General Anesthesia Drug Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare, Hikma Pharmaceuticals, Mylan, Nhwa, Lunan, Hengrui